11.28.12
Trelleborg Sealing Solutions plans to pour $7.3 million into an expansion and relocation of its life-sciences facility in Hudson, Mass. The company produces precision seals for the medical device industry among other markets. The new facility will be located in Northborough, Mass.
The new plant is scheduled to open in the first quarter of 2013, and will manufacture silicone products for original equipment manufacturers and end users in the life-science industry including pharmaceutical, medical device, biotechnology, and patient care fields. The company also intends to expand its precision liquid injection molding capabilities with more clean room space. The class 7 and 8 clean rooms will be carried over from the Hudson location.
“It’s not just expanding capacity, but also bringing expertise in liquid injection molding with liquid silicone rubber from our Switzerland facility to the United States,” said James Henderman, the Trelleborg Sealing Solutions products manager for life sciences in North America. “Trelleborg’s drive is to broaden its serviceability and product offering in North America.”
Henderman went on to say the new facility will be one of the company’s most technologically advanced, with “full automation.”
“This will allow current employees and potential new employees in the local community to be a part of a growing market within a state-of-the-art facility,” he continued. “Having a strong presence in North America is critical. Much of the R&D [research and development] within life sciences is brought to market via North America and the United States. However, the need within life sciences industry is global. As a result, Trelleborg has seen the need to have the most technically advanced international facilities to address the marketplace.”
Trelleborg Sealing Solutions is owned by Trelleborg AB, a polymers company that is headquartered in Stuttgart, Germany.
The new plant is scheduled to open in the first quarter of 2013, and will manufacture silicone products for original equipment manufacturers and end users in the life-science industry including pharmaceutical, medical device, biotechnology, and patient care fields. The company also intends to expand its precision liquid injection molding capabilities with more clean room space. The class 7 and 8 clean rooms will be carried over from the Hudson location.
“It’s not just expanding capacity, but also bringing expertise in liquid injection molding with liquid silicone rubber from our Switzerland facility to the United States,” said James Henderman, the Trelleborg Sealing Solutions products manager for life sciences in North America. “Trelleborg’s drive is to broaden its serviceability and product offering in North America.”
Henderman went on to say the new facility will be one of the company’s most technologically advanced, with “full automation.”
“This will allow current employees and potential new employees in the local community to be a part of a growing market within a state-of-the-art facility,” he continued. “Having a strong presence in North America is critical. Much of the R&D [research and development] within life sciences is brought to market via North America and the United States. However, the need within life sciences industry is global. As a result, Trelleborg has seen the need to have the most technically advanced international facilities to address the marketplace.”
Trelleborg Sealing Solutions is owned by Trelleborg AB, a polymers company that is headquartered in Stuttgart, Germany.